StockData
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

Pluri Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 10, 2026
$0.85−0.08 (-8.58%)

Close on Oct 19, 2026

Market cap
$9.08M
P/E (TTM)
–
Dividend yield
–

Pluri Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Pluri does not break out revenue by segment, region or product in the tagged data of its filings for this period type.